- Report
- April 2026
- 150 Pages
Mexico
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Netherlands
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
China
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Saudi Arabia
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
South Africa
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
South Korea
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Spain
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Thailand
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Turkey
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
United Kingdom
From €4483EUR$4,850USD£3,737GBP
- Report
- March 2026
- 327 Pages
Canada
From €4483EUR$4,850USD£3,737GBP
- Report
- March 2026
- 150 Pages
China
From €4483EUR$4,850USD£3,737GBP
- Report
- March 2026
- 163 Pages
Germany
From €4483EUR$4,850USD£3,737GBP
- Report
- March 2026
- 181 Pages
India
From €4483EUR$4,850USD£3,737GBP
- Report
- November 2025
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- September 2025
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- September 2025
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- July 2025
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- August 2023
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- January 2025
- 48 Pages
Global
From €2310EUR$2,499USD£1,925GBP

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing.
The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development.
Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more